| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
GROWTH, DIFFERENTIATION, AND APOPTOSIS
1Institut National de la Santé et de la Recherche Médicale (INSERM), U845, Paris; and 2Université Paris Descartes, Unité Mixte de Recherche en Santé (UMRS-845), Paris, France; 3Dulbecco Telethon Institute at the Venetian Institute of Molecular Medicine, Padova, Italy; and 4Cell Microscopy Center, Department of Cell Biology, University Medical Center Utrecht and Institute of Biomembranes, Utrecht, The Netherlands
Submitted 21 September 2006 ; accepted in final form 4 May 2007
A defect in protein turnover underlies multiple forms of cell atrophy. Since S6 kinase (S6K)-deficient cells are small and display a blunted response to nutrient and growth factor availability, we have hypothesized that mutant cell atrophy may be triggered by a change in global protein synthesis. By using mouse genetics and pharmacological inhibitors targeting the mammalian target of rapamycin (mTOR)/S6K pathway, here we evaluate the control of translational target phosphorylation and protein turnover by the mTOR/S6K pathway in skeletal muscle and liver tissues. The phosphorylation of ribosomal protein S6 (rpS6), eukaryotic initiation factor-4B (eIF4B), and eukaryotic elongation factor-2 (eEF2) is predominantly regulated by mTOR in muscle cells. Conversely, in liver, the MAPK and phosphatidylinositol 3-kinase pathways also play an important role, suggesting a tissue-specific control. S6K deletion in muscle mimics the effect of the mTOR inhibitor rapamycin on rpS6 and eIF4B phosphorylation without affecting eEF2 phosphorylation. To gain insight on the functional consequences of these modifications, methionine incorporation and polysomal distribution were assessed in muscle cells. Rates and rapamycin sensitivity of global translation initiation are not altered in S6K-deficient muscle cells. In addition, two major pathways of protein degradation, autophagy and expression of the muscle-specific atrophy-related E3 ubiquitin ligases, are not affected by S6K deletion. Our results do not support a role for global translational control in the growth defect due to S6K deletion, suggesting specific modes of growth control and translational target regulation downstream of mTOR.
signal transduction; atrophy; autophagy
This article has been cited by other articles:
|
|
 |
|
  C. Selman, J. M. A. Tullet, D. Wieser, E. Irvine, S. J. Lingard, A. I. Choudhury, M. Claret, H. Al-Qassab, D. Carmignac, F. Ramadani, et al. Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span Science, October 2, 2009; 326(5949): 140 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cao, J.-i. Hanai, P. Tanksale, S. Imamura, V. P. Sukhatme, and S. H. Lecker Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect FASEB J, September 1, 2009; 23(9): 2844 - 2854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Pastor, I. Garcia-Yebenes, N. Fradejas, J. M. Perez-Ortiz, S. Mora-Lee, P. Tranque, M. A. Moro, M. Pende, and S. Calvo mTOR/S6 Kinase Pathway Contributes to Astrocyte Survival during Ischemia J. Biol. Chem., August 14, 2009; 284(33): 22067 - 22078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Welle, K. Burgess, and S. Mehta Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E567 - E572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sandri Signaling in Muscle Atrophy and Hypertrophy Physiology, June 1, 2008; 23(3): 160 - 170. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
